Therapeutics Archives - Occasional Digest

MONEY

Io Therapeutics, Inc., announces presentation of data on its RAR gamma agonist compound IRX5010 demonstrating inhibition of tumor infiltrating myeloid derived suppressor cells, promotion of tumor infiltrating T-cells, and effective tumor growth inhibition in murine models of breast, colorectal, and prostate cancers

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…

MONEY

Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 5, 2024 Finance Desk

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…

MONEY

STOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger and its Tender Offer for Calliditas Therapeutics AB – CALT

Jul 27, 2024 Finance Desk

Article contentNEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 27, 2024 / GlobeNewswire/–Monteverde & Associates PC (the “M&A Class Action Firm”), has…

MONEY

Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

Jul 27, 2024 Finance Desk

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…

MONEY

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal aging-related neurodegeneration, Parkinson’s disease, and Alzheimer’s disease

Jul 10, 2024 Finance Desk

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…

MONEY

Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update

Apr 27, 2024 Finance Desk

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…

MONEY

Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.

Apr 26, 2024 Finance Desk

This section is Partnership Content suppliedThe content in this section is supplied by GlobeNewswire for the purposes of distributing press releases on behalf of its…

NEWS TOP NEWS

Trade commission fights Amgen’s $28B purchase of Horizon Therapeutics

May 16, 2023 News Desk

May 16 (UPI) -- The Federal Trade Commission said on Tuesday it will try to block an effort by biopharmaceutical leader Amgen Inc. from purchasing…

Occasional Digest

Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

STOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger and its Tender Offer for Calliditas Therapeutics AB – CALT

Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

Rakovina Therapeutics Inc. Announces 2023 Financial Results and Provides Corporate Update

Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.

Trade commission fights Amgen’s $28B purchase of Horizon Therapeutics

You missed

How the genocide destroyed our sea | Israel-Palestine conflict

MAFS UK chaos ahead of final vows as cast leak spoilers, turn on show bosses in furious rants and reveal splits

US sanctions RSF commander accused of rights abuses in Sudan’s Darfur | Conflict News

High court rejects push to move case against ex-Trump chief of staff

Occasional Digest